Unknown NA INTERVENTIONAL 1-arm NCT04667403

Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer (PANTELO)

Sponsor: Institut Cancerologie de l'Ouest

Conditions Adenocarcinoma Pain Pancreatic Cancer Metastatic

Updated 5 times since 2021 Last updated: Apr 21, 2022 Started: Feb 7, 2022 Primary completion: Nov 8, 2023 Completion: Feb 8, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Adenocarcinoma and Pain and is currently ongoing. Institut Cancerologie de l'Ouest leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
May 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
May 2022 — May 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2021 — May 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Cancerologie de l'Ouest

Data source: Institut Cancerologie de l'Ouest

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saint-Herblain, France